# ArrowMark Partners' Biotech Investments: 13 Startups in Its Portfolio (2026) > The 13 Biotech startups ArrowMark Partners has backed, by stage: $2.8B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/arrowmark-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 6 - [Moderna](https://millionrounds.com/company/moderna) - [Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics) - [Metacrine](https://millionrounds.com/company/metacrine) - [*A* Ascentage](https://millionrounds.com/company/ascentage) - [ArcherDX](https://millionrounds.com/company/archerdx) - [*C* Centrexion](https://millionrounds.com/company/centrexion) ## Series B 5 - [SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics) - [Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics) - [*T* TCR2](https://millionrounds.com/company/tcr2) - [Lyra Therapeutics](https://millionrounds.com/company/lyra-therapeutics) - [NextCure](https://millionrounds.com/company/nextcure) ## Stage not reported 2 - [Dren Bio](https://millionrounds.com/company/dren-bio) - [Kodiak](https://millionrounds.com/company/kodiak) ## Segment by segment ### Series C and later 6 startups · $1.6B raised - [**Moderna**](https://millionrounds.com/company/moderna) Learn how we’re changing the world of medicine. United States $675M - [**Orchard Therapeutics**](https://millionrounds.com/company/orchard-therapeutics) Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies. United Kingdom $377M - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M - [*A* **Ascentage**](https://millionrounds.com/company/ascentage) United States $150M - [**ArcherDX**](https://millionrounds.com/company/archerdx) ArcherDX is a biotechnology firm specializing in cancer research. United States $150M - [*C* **Centrexion**](https://millionrounds.com/company/centrexion) United States $90M ### Series B 5 startups · $737M raised - [**SpringWorks Therapeutics**](https://millionrounds.com/company/springworks-therapeutics) SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer. United States $400M - [**Neon Therapeutics**](https://millionrounds.com/company/neon-therapeutics) NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer. United States $161M - [*T* **TCR2**](https://millionrounds.com/company/tcr2) United States $125M - [**Lyra Therapeutics**](https://millionrounds.com/company/lyra-therapeutics) Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases. United States $30M - [**NextCure**](https://millionrounds.com/company/nextcure) NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. United States $22M ### Stage not reported 2 startups · $408M raised - [**Dren Bio**](https://millionrounds.com/company/dren-bio) Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. United States $375M - [**Kodiak**](https://millionrounds.com/company/kodiak) Kodiak, a division of Motorola Solutions based in Plano, Texas, specializes in broadband push-to-talk (PTT) communication platform United States $33M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names ArrowMark Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with ArrowMark Partners** 21 co-investors](https://millionrounds.com/portfolio-maps/arrowmark-partners-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio)[Sector portfolio **Gaingels' AI portfolio** 146 startups · $14B](https://millionrounds.com/portfolio-maps/gaingels-ai-portfolio)[Sector portfolio **Cormorant Asset Management's Biotech portfolio** 95 startups · $21B](https://millionrounds.com/portfolio-maps/cormorant-asset-management-biotech-portfolio) ## Raising from investors like ArrowMark Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)